Portfolio, Press Eclipsebio Launches eMERGE™ Platform, a Cutting-Edge End-to-End Solution for the Characterization and Optimization of RNA-Based Therapeutic Products Posted on August 1, 2024 by iGlobe Partners Orbital Therapeutics Acquired by Bristol-Myers